📚 Lecture Overview
This lecture covers the clinical approach to evaluating short stature in pediatric patients, differentiating between physiological and pathological causes. It details diagnostic steps including bone age assessment, mid-parental height calculation, growth hormone stimulation tests, and targeted management strategies. Mastering this material is essential for diagnosing endocrine disorders, skeletal dysplasias, and systemic illnesses that impact pediatric growth.
🎯 Key Concepts & Definitions
- Short Stature: Height below the 3rd centile, or more than 2 standard deviations below the median height for age and sex.
- Chronological Age: The actual calendar age of the child.
- Height Age: The age at which the child's height sits precisely at the 50th centile.
- Bone Age: An indicator of skeletal maturation, typically estimated via an X-ray of the left wrist and hand.
- Target Mid-Parental Height (MPH): Calculated expected adult height based on parental heights (Boys: [F+M]/2 + 6.5; Girls: [F+M]/2 - 6.5).
- Upper to Lower Segment Ratio (U/L Ratio): A body proportion metric that helps differentiate between proportionate and disproportionate short stature.
- Constitutional Delay: A physiological pattern of growth featuring delayed puberty and delayed bone age, but ultimately resulting in a normal final adult height.
- Familial Short Stature: A physiological variant where a child grows along a low target centile with a bone age matching their chronological age, leading to a short final height within the family range.
- Psychosocial Short Stature: Emotional or maternal deprivation dwarfism causing functional hypopituitarism and low IGF-1 levels, which reverses in a stress-free environment.
📖 Main Content
1. Classification of Short Stature Causes
The underlying etiologies of short stature are broadly split into two categories:
- Physiological Causes:
- Familial Short Stature
- Constitutional Delay of Growth and Puberty
- Pathological Causes:
- Undernutrition and chronic systemic diseases
- Endocrine causes (e.g., Growth Hormone Deficiency, hypothyroidism)
- Psychosocial dwarfism
- Small for Gestational Age (SGA) babies
- Skeletal dysplasias (e.g., Achondroplasia)
- Genetic syndromes (e.g., Turner syndrome)
2. Differentiating Familial vs. Constitutional Short Stature
- Familial Short Stature:
- Normal birth size, catch-down growth by 2 years.
- Bone age = chronological age.
- Normal puberty timing; final height is low but matches the target family range.
- Constitutional Short Stature:
- Normal birth size, deceleration of growth between 6 months to 3 years, then normal growth velocity parallel to the 3rd percentile.
- Bone age < chronological age (Bone age equals height age).
- Delayed puberty with a normal final adult height.
3. Body Proportions and Segment Analysis
- The body is divided into the Upper Segment (US) and Lower Segment (LS), where LS spans from the symphysis pubis to the floor.
- U/L ratio changes with age: 1.7 at birth, 1.3 at 3 years, and 1.0 after 7 years.
- Disproportionate Short Stature:
- Increased U/L ratio indicates short lower limbs (e.g., achondroplasia).
- Decreased U/L ratio indicates a short trunk (e.g., scoliosis) or short neck (e.g., Turner syndrome).
4. Diagnostic Evaluation and Bone Age Patterns
- Pathological short stature pattern: Bone Age < Height Age < Chronological Age (BA < HA < CA).
- Bone Age Interpretations:
- BA = CA: Familial short stature, precocious puberty.
- BA = HA: Constitutional delay, undernutrition, systemic illness.
- BA < HA: Growth Hormone Deficiency (GHD), hypothyroidism.
- Investigation Tiers:
- Level One: Complete hemogram with ESR, bone age X-ray, urinalysis, stool examination, RFT, LFT, FBS.
- Level Two: Thyroid function tests (TFT), karyotyping.
- Level Three: Celiac serology, GH stimulation tests.
5. Growth Hormone Testing and Interpretation
- Random GH sampling is useless due to pulsatile secretion (peaks during sleep).
- Provocative Agents: Insulin tolerance test (ITT), glucagon, L-dopa, arginine, clonidine.
- Stimulation Test Thresholds:
- Normal peak GH: $≥ 10$ ng/ml
- Partial GHD: 8–10 ng/ml
- GHD: $< 3$ ng/ml
- IGF-1 and IGFBP-3: Normal levels rule out GHD. Low levels with low GH confirm GHD; low levels with normal/high GH suggest GH resistance (e.g., Laron syndrome).
6. Management and Growth Hormone Therapy
- Indications for GH Therapy: GHD, Turner syndrome, Prader-Willi syndrome, chronic renal insufficiency (CRI), and SGA children with growth failure at $≥ 4$ years.
- Dosage Variations:
- GHD: 23–39 µg/kg/day
- Turner syndrome & CRI: 45–50 µg/kg/day
- SGA: 35 µg/kg/day
- Discontinuation Criteria: Final height attained, patient choice, poor growth velocity response ($< 50%$ gain in year 1, or $< 2$ cm/year), bone age advanced (>14 years in girls, >16 years in boys), or non-adherence.
- Side Effects: Pseudotumor cerebri, hyperglycemia, acute pancreatitis, liver abnormalities, and gynecomastia.
📊 Visual Learning
flowchart TD
A[Short Stature] --> B{Bone Age vs Chronological Age}
B -->|BA equals CA| C[Familial Short Stature]
B -->|BA less than CA| D{Bone Age vs Height Age}
D -->|BA equals HA| E[Constitutional Delay]
D -->|BA less than HA| F[Pathological GHD or Hypothyroidism]
mindmap
root("Short Stature Causes")
"Physiological"
"Familial"
"Constitutional Delay"
"Pathological Endocrine"
"Growth Hormone Deficiency"
"Hypothyroidism"
"Pathological Systemic"
"Undernutrition"
"Chronic Renal Failure"
"Celiac Disease"
"Genetic and Skeletal"
"Turner Syndrome"
"Achondroplasia"
"SGA Babies"
flowchart LR
A[Low IGF-1] --> B[GH Stimulation Test]
B -->|Low Peak GH| C[Growth Hormone Deficiency]
B -->|Normal Peak GH| D[GH Resistance or Laron Syndrome]
💡 Important Points to Remember
- Short stature is definitively marked by height below the 3rd centile or $> 2$ standard deviations below the median.
- Target MPH Formula: Boys =
(F + M)/2 + 6.5; Girls =(F + M)/2 - 6.5. - Bone age is evaluated using an X-ray of the left wrist and hand (Greulich and Pyle method).
- Constitutional delay features delayed bone age matching the height age, and concludes with a normal final height.
- Random growth hormone levels are clinically useless; a provocative GH stimulation test is required to diagnose GHD.
- A normal peak GH response on a stimulation test is $≥ 10$ ng/ml, while a peak $< 3$ ng/ml indicates GHD.
- Turner syndrome girls and children with chronic renal insufficiency require a higher GH dose (45–50 µg/kg/day) compared to standard GHD treatment.
- Common exam confusion: Confusing bone age clues. Remember: BA = HA points to constitutional delay/undernutrition, whereas BA < HA points to endocrine problems like GHD or hypothyroidism.
- Monitor for key side effects of GH therapy including pseudotumor cerebri and hyperglycemia.
- Psychosocial short stature is functionally reversible when the child is removed from an environment of emotional deprivation.
⚠️ Common Exam Questions
- The "Bone Age Math" Trap: Examiners love to give clinical vignettes describing a child's ages (CA, HA, BA) and ask for the likely diagnosis.
- Trick: A student might confuse constitutional delay (BA = HA) with GHD (BA < HA). Always check the relationship between bone age and height age carefully.
- GH Stimulation Misconception: Multiple-choice questions often suggest checking a single random serum GH level to diagnose GHD.
- Trap: Remember that random GH is worthless due to pulsatile secretion; a provocative test or IGF-1/IGFBP-3 assessment is mandatory.
- Proportionate vs. Disproportionate Stature: Expect questions mapping specific syndromes (like achondroplasia or Turner syndrome) to U/L segment ratio changes (e.g., short lower limbs vs. short neck/trunk).
📝 Quick Review Checklist
I can explain the formal definition of short stature
I understand the difference between familial and constitutional short stature
I can define chronological age, height age, and bone age
I know how to calculate Mid-Parental Height for boys and girls
I understand body proportions and U/L ratio variations
I can interpret bone age patterns (BA = CA vs. BA = HA vs. BA < HA)
I know the diagnostic cutoffs for Growth Hormone Deficiency on stimulation tests
I know the key indications, dosages, and side effects of GH therapy